2008 Press Releases
2007 Press Releases
2006 Press Releases
2005 Press Releases
Investor Events Calendar
November 16, 2005
Chairman’s Address for ChemGenex Pharmaceuticals Limited Annual General Meeting
November 08, 2005
ChemGenex To Present At Rodman & Renshaw Techvest 7th Annual Healthcare Conference
October 10, 2005
ChemGenex Team Pinpoints Inflammation Gene
October 05, 2005
ChemGenex Initiates New Phase 2 Trial of Ceflatonin® in Gleevec® Resistant CML
September 27, 2005
ChemGenex Personalized Medicine Clinical Trial Expanded to Patients with Breast and Ovarian Cancers
August 30, 2005
2004-05 Financial Report Highlights Successful Year For ChemGenex
August 04, 2005
ChemGenex Joins New NASDAQ Health Care Index
July 28, 2005
ChemGenex Appoints Two Experienced Directors To Board
July 27, 2005
Australian Research Council Supports Two New Obesity & Type 2 Diabetes Studies by ChemGenex Pharmaceuticals’ Researchers
July 18, 2005
ChemGenex Announces Strategy for Registration-Directed Clinical Trials for Ceflatonin®
July 04, 2005
Investor Update Teleconference
June 27, 2005
ChemGenex and Stragen Pharma Create Alliance to Accelerate Clinical Development and Commercialization of Ceflatonin®
June 27, 2005
ChemGenex To List On NASDAQ
May 02, 2005
ChemGenex To Present At Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference
April 22, 2005
ChemGenex Presents at the Molecular Medicine Tri-Conference in San Francisco
April 07, 2005
ChemGenex Launches Multi-Centre Phase 2 Clinical Trial of Ceflatonin® in Combination with Gleevec® in Patients with Chronic Myelogenous Leukemia
February 23, 2005
ChemGenex To Present At The Bio CEO & Investor Conference 2005
February 23, 2005
ChemGenex To Receive Significant Milestone Payment From Vernalis
February 17, 2005
ChemGenex Pharmaceuticals Receives European Allowance For Cancer Drug Patent
February 09, 2005
ChemGenex Licenses Targeted Platinum (IV) Compound From M.D. Anderson Cancer Center In Texas
February 08, 2005
ChemGenex Presents Positive Clinical Trial Data
January 24, 2005
ChemGenex Raises US$6.2 Million (A$8.2 Million) In International Placement
© 2005 ChemGenex Pharmaceuticals |
Terms of Use
